Related Experiment Video
Updated: Sep 23, 2025
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through
Sylvie Bouvier1, Waël Traboulsi2, Sandra M Blois3
1Department of Hematology, Nîmes University Hospital, Nîmes, France; Faculty of Pharmaceutical and Biological Sciences, University of Montpellier, Montpellier, France; UA11 Institut National de la Santé et de la Recherche Médicale (INSERM)-University of Montpellier (UM) Institut Desbrest d'Epidémiologie et de Santé Publique (IDESP), Montpellier, France.
Objective:
To explore the regulatory role of soluble CD146 (sCD146) and its interaction with galectin-1 (Gal1) in placenta-mediated complications of pregnancy.
Design:
Prospective pilot and experimental studies.
Setting:
University-affiliated hospital and academic research laboratory.
Patient(S):
One hundred fifteen women divided into three groups: 30 healthy, nonpregnant women, 50 women with normal pregnancies, and 35 with placenta-mediated pregnancy complications.
Intervention(S):
Wound-healing experiments were conducted to study trophoblast migration.
Main Outcome Measure(S):
Quantification of sCD146 and Gal1 by enzyme-linked immunosorbent assay. Analysis of trophoblast migration by wound closure.
Result(S):
Concomitant detection of sCD146 and Gal1 showed lower sCD146 and higher Gal1 concentrations in women with normal pregnancies compared with nonpregnant women. In addition, follow-up of these women revealed a decrease in sCD146 associated with an increase in Gal1 throughout pregnancy. In contrast, in women with preeclampsia, we found significantly higher sCD146 concentrations compared with women with normal pregnancies and no modification of Gal1. We emphasize the opposing effects of sCD146 and Gal, since, unlike Gal1, sCD146 inhibits trophoblast migration. Moreover, the migratory effect of Gal1 was abrogated with the use of an anti-CD146 blocking antibody or the use of small interfering RNA to silence VEGFR2 expression. This suggests that trophoblast migration is mediated though the interaction of Gal1 with CD146, further activating the VEGFR2 signaling pathway. Significantly, sCD146 blocked the migratory effects of Gal1 on trophoblasts and inhibited its secretion, suggesting that sCD146 acts as a ligand trap.
Conclusion(S):
Soluble CD146 could be proposed as a biomarker in preeclampsia and a potential therapeutic target.
Clinical Trial Registration Number:
NCT 01736826.
More Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
01:15Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
01:25Selectins
01:17Intracellular Signaling Affects Focal Adhesions
Some...